Asia accounted for more than 40% of the world's Non-Hodgkin Lymphoma incidence in 2020, with China contributing the majority.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more